Pharmaceutical company Johnson & Johnson will pay $230 million to settle an opioid lawsuit with the state of New York, the state’s attorney general said Saturday. According to arelease from New York AG Letitia James, Johnson & Johnson “has committed to ending the manufacture and sale of ...
Johnson & Johnson will pay $230 million to resolve an opioids lawsuit, days before the company was slated to go to trial, in a settlement reached with New York Attorney General Letitia James. In the agreement, the company will end the sale of all opioid products nationwide, James' office ...
The settlement money will be used to to fund opioid prevention, treatment and education efforts across the state, according to James. Payments for more than half of the $230 million will be accelerated and paid by February 2022. Johnson & Johnson said it has not marketed opioids in the U.S...
Johnson & Johnson, one of the pharmaceutical giants accused of fueling the deadly US opioid crisis, has reached a settlement with the state of New York for $230 million and confirmed it will stop making or selling opioids in the United States. The agreement announced Saturday allows Johnson & ...